Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliers
advertisement
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
MEDICA 2025
-
Pharmig’s 33rd Annual Conference
-
Confience LIMS Launchpad Series: Episode #5 - Return on Investment
-
PharmaLab Congress and Exhibition 2025
-
XXIII Workshop on Rapid Methods and Automation in Food Microbiology (MRAMA) - DYCFung Memorial
-
2025 ISPE Pharma 4.0™ Conference
-
Endotoxin Masterclass: Comprehensive Training in Modern Testing Methods
-
10th Anniversary Microbiome Movement Summit
-
WHX Labs Dubai
-
World Water-tech Innovation Summit
